EMLA cream for pain during lymphoscintigraphy for skin cancer
Part of Cancer, Infections, Skin clinical trials.
This trial tests whether EMLA cream can reduce pain from injections needed to map lymph nodes for certain skin cancers. If you are scheduled for lymphoscintigraphy and sentinel lymph node biopsy, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 99 years old
- You have a skin cancer diagnosis such as melanoma, Merkel cell, squamous cell, or other skin cancer requiring lymph node mapping
- You can receive the injection used for lymph node mapping (no known allergy to the tracer or local anesthetics)
- You do not have chronic pain lasting 3 months or more that requires narcotics
- You are not pregnant, incarcerated, or unable to give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized cell therapy called TIL (tumor-infiltrating lymphocytes) for people with advanced skin cancers that have not responded to immunotherapy. Doctors take your tumor cells, grow immune cells from them, and then infuse them back to fight the cancer.
This early-phase study tests cemiplimab (an immune therapy that helps your immune system attack cancer) given before surgery. It aims to shrink tumors and improve outcomes for people with Merkel cell cancer or certain locally advanced skin squamous cell cancers (CSCC).
This study looks at how insurance covers immunotherapy given before surgery for certain skin cancers. It includes people with Merkel cell, mucosal melanoma, basal cell, or other rare skin cancers who are planning to have surgery.
This study tests local anesthetics (numbing medicines) used during Mohs micrographic surgery, a specialized procedure for skin cancer. Researchers want to understand how well these numbing agents work and improve patient comfort during the procedure.
This study tests two methods, a mild electrical nerve stimulation and a vibrating device, used during the numbing injection for skin surgery to see if they reduce pain. Participants will be randomly assigned to one of the methods during their procedure.
This trial tests a special marker that numbs the skin before medical procedures. It may help reduce pain during injections or minor skin treatments.
Hear when a new Cutaneous Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.